HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxcarbazepine treatment of bipolar disorder.

AbstractOBJECTIVE:
To assess the effectiveness and safety of oxcarbazepine in bipolar disorder.
METHOD:
A chart review of naturalistic treatment with oxcarbazepine in 42 outpatients with DSM-IV bipolar disorder (10 males, 32 females; mean +/- SD age = 33.3 +/- 12.4 years; 25 with bipolar disorder type I, 4 with bipolar disorder type II, and 13 with bipolar disorder not otherwise specified) was conducted. Patients had received oxcarbazepine monotherapy or adjunctive therapy between April 2000 and April 2002. Treatment response was defined as a Clinical Global Impressions-Improvement scale score of 1 (marked improvement) or 2 (moderate improvement).
RESULTS:
Oxcarbazepine was moderately to markedly effective in 24 subjects (57%). Mixed symptoms were the most common indication (52% [22/42]). The mean oxcarbazepine dose was 1056.6 mg/day, and mean treatment duration was 16.2 weeks. Sedation (17/42, 40%) was the most common side effect, but 16 patients (38%) had no side effects. Twenty-two patients (52%) stopped treatment, mostly due to side effects (12/22). Males were more likely to respond than females (10/10 vs. 14/32, p =.006). Dose, bipolar subtype, indication, past nonresponse to mood stabilizers, concurrent mood stabilizer use, and monotherapy use of oxcarbazepine did not differentially predict response.
CONCLUSION:
Oxcarbazepine appeared effective in about one half of patients with bipolar disorder and was well tolerated.
AuthorsS Nassir Ghaemi, Douglas A Berv, Jeffry Klugman, Klara J Rosenquist, Douglas J Hsu
JournalThe Journal of clinical psychiatry (J Clin Psychiatry) Vol. 64 Issue 8 Pg. 943-5 (Aug 2003) ISSN: 0160-6689 [Print] United States
PMID12927010 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anticonvulsants
  • Carbamazepine
  • Lithium
  • Oxcarbazepine
Topics
  • Adolescent
  • Adult
  • Ambulatory Care
  • Anticonvulsants (therapeutic use)
  • Bipolar Disorder (diagnosis, drug therapy, psychology)
  • Carbamazepine (analogs & derivatives, therapeutic use)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Lithium (therapeutic use)
  • Male
  • Medical Records
  • Middle Aged
  • Oxcarbazepine
  • Patient Dropouts
  • Pilot Projects
  • Psychiatric Status Rating Scales
  • Sex Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: